China Everbright International expects industrial investments in China to contribute more profit this year. General manager Chen Dagang said the company's key industrial investment, New York-listed China Yuchai International, was expecting higher sales and profit this year because its only asset, 76.4 per cent-owned Guangxi Yuchai, had quickened the collection of sales revenue. Diesel engine manufacturer Guangxi Yuchai increased its market share to 49 per cent last year from 33 per cent in 1994. Everbright also expects profit contribution to increase from Shenzhen 999 Pharmaceutical Co. Deputy general manager Alexis Wong said profit from Shenzhen 999 should exceed the 14.3 million yuan (about HK$13.29 million) it contributed last year. Executive director Tong Xin said industrial investment would remain the group's core business, which accounted for more than 50 per cent of its assets. With cash in hand of more than $100 million, he said Everbright was seeking new investment projects in China.